Investing.com - Revance The reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Revance The announced earnings per share of $-0.70 on revenue of $29.02M. Analysts polled by Investing.com anticipated EPS of $-0.79 on revenue of $28.04M.
Revance The shares are down 16% from the beginning of the year, still down 30.89% from its 52 week high of $30.95 set on October 7.
Revance The follows other major Healthcare sector earnings this month
Revance The's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar